A Canadian perspective on the eighth Joint National Committee (JNC 8) hypertension guidelines

Journal of Clinical Hypertension

Volumn 16, Issue 4, 2014, Pages 246-248

  Myers, Martin G ^a   Tobe, Sheldon W ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CANADA; EDUCATION PROGRAM; EVIDENCE BASED PRACTICE; HUMAN; HYPERTENSION; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; COMPARATIVE STUDY; INTERNATIONAL COOPERATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; STANDARDS;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CANADA; HUMANS; HYPERTENSION; INTERNATIONALITY; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL;

EID: 84898923208     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12307     Document Type: Article

References (19)

1. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 5: 507-520
2. Hackam DG, Quinn RR, Ravani P, et al. The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention and treatment of hypertension. Can J Cardiol. 2013;29:528-542.
3. Sibley JC, Spitzer WO, Rudnick KV, et al. Quality of care appraisal in primary care. A quantitative method. Ann Int Med 1975;83:46-52.
4. National Institute for Health and Clinical Excellence: Hypertension NICE Clinical Guidelines 127. National Clinical Guidelines Centre. London, UK, August, 2011.
5. Mancia G, Fagard F, Narkiewicz K, et al. ESH/ESC guidelines for the management of arterial hypertension. J Hypertens. 2013;31:1281-1357.
6. Head GA, McGrath BP, Mihailidou AS, et al. Ambulatory blood pressure monitoring n Australia: 2011 consensus position statement. J Hypertens. 2012;30:253-266.
7. Feldman RD, Campbell N, Larochelle P, et al. Canadian recommendations for the management of hypertension. CMAJ. 1999;161(suppl 12):S1-S22.
8. Myers MG, Tobe SW, McKay DW, et al. on behalf of the Canadian Hypertension Education Program. New algorithm for the diagnosis of hypertension.- Canadian Hypertension Education Program recommendations (2005). Am J Hypertens. 2005;18:1369-1374.
9. Hemmelgarn BR, McAlister FA, Myers MG, et al. for the Canadian Hypertension Education Program. The 2005 Canadian Hypertension Education Program (CHEP) recommendations for the management of hypertension. Part 1: blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol. 2005;21:645-656.
10. Campbell NRC, Brant R, Johansen H, et al. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension. 2009;53:128-134.
11. Leenen FHH, Dumais J, McInnis N, et al. Ontario survey on the prevalence and control of hypertension (ON BP). CMAJ. 2008;178:1441-1449.
12. Wilkins K, Campbell NRC, Joffres MR, et al. Blood pressure in Canadian adults. Health Rep (Statistics Canada). 2010;21:1-10.
13. Myers MG. Implications of ambulatory blood pressure monitoring substudies on the interpretation of clinical trials in hypertension: should the threshold be lower in older patients. J Clin Hypertens (Greenwich). 2013;13:703-705.
14. Arima H, Chalmers J, Woodward M, et al. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens. 2006;24:1201-1208.
15. Accord Study Group. Effects of intensive blood pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575-1585.
16. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) trial. Lancet. 1998;351:1755-1762.
17. Hansson L, for the HOT Study Group. The Hypertension optimum treatment study. Blood Press. 1993;2:62-68.
18. Rabi DM, Padwal R, Tobe SW, et al. Risks and benefits of intensive blood pressure lowering in patients with type 2 diabetes. CMAJ. 2013;185:963-967.
19. Kuyper LM, Khan NA. Atenolol vs non-atenolol β-blockers for the treatment of hypertension: a meta-analysis. Can J Cardiol. 2014 Jan 17; DOI: 10.1016/j.cjca.2014.01.006.